Stokes Family Office’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $231K | Buy |
2,082
+5
| +0.2% | +$554 | 0.02% | 216 |
|
|
2025
Q1 | $233K | Buy |
+2,077
| New | +$233K | 0.03% | 216 |
|
|
2023
Q3 | – | Sell |
-2,606
| Closed | -$201K | – | 349 |
|
|
2023
Q2 | $201K | Buy |
2,606
+143
| +6% | +$11K | 0.02% | 301 |
|
|
2023
Q1 | $204K | Sell |
2,463
-217
| -8% | -$18K | 0.03% | 277 |
|
|
2022
Q4 | $230K | Buy |
+2,680
| New | +$230K | 0.03% | 246 |
|